Objectives: To compare between C-reactive protein (CRP) and Procalcitonin (PCT) regarding diagnosis and outcome of neonatal sepsis.
Design: Prospective observational study.
Setting: Neonatal Intensive Care Unit (NICU).
Participants: Seventy newborn Infants admitted to NICU for sepsis management.
Results: Of the total 70 Neonates admitted in NICU, 31.4%, 42.9% and 25.7% were categorized as proven sepsis, suspected sepsis and clinical sepsis respectively. Procalcitonin was positive in 100% compared to the CRP positivity in 63.6% of the proven sepsis cases. Mortality rate is significantly increased in proven sepsis compared to clinical sepsis.
Intervention: Sepsis workup laboratory tests.
Main Outcome Measures: Specific diagnostic and prognostic impact of the tests.
Conclusion: Comparing with CRP, PCT is not only a good diagnostic measure of neonatal sepsis but also effective predictor of sepsis outcome.
Keywords:Procalcitonin; CRP; Neonatal; Sepsis; UTI
View Full text and Pdf
View Journal of Immunology and Infectious Diseases (JIID)